Fredag 12 Juni | 00:34:15 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-11-10 07:00 Kvartalsrapport 2026-Q3
2026-07-23 07:00 Kvartalsrapport 2026-Q2
2026-05-27 - X-dag ordinarie utdelning MNTC 0.00 SEK
2026-05-26 - Årsstämma
2026-05-07 - Kvartalsrapport 2026-Q1
2026-02-26 - Extra Bolagsstämma 2026
2026-02-26 - Bokslutskommuniké 2025
2025-11-06 - Kvartalsrapport 2025-Q3
2025-07-24 - Kvartalsrapport 2025-Q2
2025-05-23 - X-dag ordinarie utdelning MNTC 0.00 SEK
2025-05-22 - Årsstämma
2025-05-08 - Kvartalsrapport 2025-Q1
2025-02-13 - Bokslutskommuniké 2024
2024-11-07 - Kvartalsrapport 2024-Q3
2024-07-23 - Kvartalsrapport 2024-Q2
2024-05-24 - X-dag ordinarie utdelning MNTC 0.00 SEK
2024-05-23 - Årsstämma
2024-05-03 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-07-20 - Kvartalsrapport 2023-Q2
2023-05-12 - X-dag ordinarie utdelning MNTC 0.00 SEK
2023-05-11 - Årsstämma
2023-04-27 - Kvartalsrapport 2023-Q1
2023-02-03 - Bokslutskommuniké 2022
2022-10-26 - Kvartalsrapport 2022-Q3
2022-07-21 - Kvartalsrapport 2022-Q2
2022-04-28 - X-dag ordinarie utdelning MNTC 0.00 SEK
2022-04-28 - Kvartalsrapport 2022-Q1
2022-04-27 - Årsstämma
2022-02-03 - Bokslutskommuniké 2021
2021-10-28 - Kvartalsrapport 2021-Q3
2021-07-22 - Kvartalsrapport 2021-Q2
2021-05-07 - X-dag ordinarie utdelning MNTC 0.00 SEK
2021-05-06 - Årsstämma
2021-04-28 - Kvartalsrapport 2021-Q1
2021-02-04 - Bokslutskommuniké 2020
2020-11-12 - Kvartalsrapport 2020-Q3
2020-08-13 - Kvartalsrapport 2020-Q2
2020-05-28 - X-dag ordinarie utdelning MNTC 0.00 SEK
2020-05-27 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-27 - Bokslutskommuniké 2019
2019-11-25 - Kvartalsrapport 2019-Q3
2019-08-29 - Kvartalsrapport 2019-Q2
2019-08-28 - Extra Bolagsstämma 2019

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Mentice är verksamt inom medicinteknik. Bolaget utvecklar medicinska instrument för endovaskulär simulering samt för träningstillfällen inom kirurgi. Programmen är utvecklade för att användas i utbildningssyfte bland sjukhus och institut. Störst verksamhet återfinns inom Nordamerika och Europa. Utöver huvudverksamheten erbjuds möjligheter till leasing, support, samt teknisk service. Huvudkontoret finns beläget i Göteborg.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-06-01 20:00:00

Gothenburg, Sweden – June 2026 – Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers, a leading medical technology company. The agreement enables access to Ankyras® clinical decision-support software with the Siemens Healthineers ARTIS icono angiography systems and includes joint promotional activities through the ARTIS icono product platform.

The partnership aims to expand clinician access to advanced, patient-specific aneurysm treatment planning by combining the state-of-the-art angiography systems by Siemens Healthineers with Mentice predictive modeling software. Ankyras® is commercially available in the EU, the United States, and Brazil.

Interoperable access to Ankyras® on ARTIS icono

Through this agreement, clinicians using ARTIS icono systems will be able to seamlessly access Ankyras® as part of their clinical workflow. Imaging data acquired on ARTIS icono can be transferred directly to Ankyras®, allowing physicians to virtually plan and simulate flow-diverter treatments using patient-specific anatomy.

Ankyras® supports interventional neuroradiologists in selecting a flow-diverter device by predicting device behavior, including foreshortening and landing zones, prior to the procedure. This enables more informed decision-making and supports procedural confidence without additional radiation exposure or patient risk.

By enabling the use of Ankyras® in the angio-suite environment, the collaboration brings advanced treatment planning closer to routine clinical practice, helping clinicians prepare for complex intracranial aneurysm cases with greater precision and efficiency.

Co-marketing activities to drive visibility and adoption

The co-marketing agreement includes a broad set of collaborative activities designed to increase awareness and adoption of Ankyras® in combination with ARTIS icono systems. The collaboration spans co-branded digital presence, inclusion of Ankyras in the Siemens Healthineers sales and customer engagements, and coordinated promotional activities across events, education, and digital channels.

These initiatives leverage the global commercial reach of Siemens Healthineers as well as Mentice clinical simulation expertise to promote an interoperable solution that supports improved planning and workflow efficiency in neurointerventional care.

Advancing patient-specific treatment planning

Ankyras® is Mentice clinical decision-support application focused on medical device planning for intracranial aneurysms. By combining Ankyras® with ARTIS icono, clinicians can move seamlessly from imaging to simulation, furthering the integrated Mentice VIST & Siemens Healthineers “virtual patient” approach to treatment planning directly connected to the clinical environment as published in 2021.